Testing Ganyan-1 eye drops for dry eye
Treatments studied
Part of Eyes & vision clinical trials.
This trial tests a new eye drop called Ganyan-1 for people with long-term dry eye. If you have had dry eye for at least 6 months and are between 18 and 70, this study may help find a better treatment option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had dry eye symptoms for at least 6 months.
- You do not have autoimmune diseases or eye cancer.
- You do not have an active eye infection or eye allergy.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.
This trial tests a new eye drop gel (CsA-PG) for people with dry eye disease. Participants must have had dry eyes for at least 6 months and meet specific eye exam scores. The study checks if the gel can improve symptoms and eye health.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.